Loading...
XNASTLRY
Market cap1.27bUSD
Dec 24, Last price  
1.41USD
1D
-1.40%
1Q
-16.07%
IPO
-95.26%
Name

Tilray Inc

Chart & Performance

D1W1MN
XNAS:TLRY chart
P/E
P/S
1.61
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
29.56%
Rev. gr., 5y
35.11%
Revenues
789m
+25.80%
00443,7036,466,44715,171,30828,629,592175,247,597390,996,128513,085,000628,372,000627,124,000788,942,000
Net income
-245m
L-83.02%
000305,1233,116,47622,837,28900-336,014,000-434,132,000-1,443,000,000-244,981,000
CFO
-31m
L
00003,953,120000-44,717,000-177,262,0007,906,000-30,905,000
Earnings
Jan 07, 2025

Profile

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
IPO date
Jul 19, 2018
Employees
1,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑052016‑052015‑05
Income
Revenues
788,942
25.80%
627,124
-0.20%
628,372
22.47%
Cost of revenue
816,948
711,782
741,734
Unusual Expense (Income)
NOPBT
(28,006)
(84,658)
(113,362)
NOPBT Margin
Operating Taxes
(26,616)
(7,181)
(6,542)
Tax Rate
NOPAT
(1,390)
(77,477)
(106,820)
Net income
(244,981)
-83.02%
(1,443,000)
232.39%
(434,132)
29.20%
Dividends
(7,484,000)
Dividend yield
346.37%
Proceeds from repurchase of equity
8,619
253,823
BB yield
-0.64%
-11.75%
Debt
Debt current
38,960
224,262
92,649
Long-term debt
413,870
376,228
549,189
Deferred revenue
113,630
Other long-term liabilities
113,720
11,104
191
Net debt
184,449
139,590
210,927
Cash flow
Cash from operating activities
(30,905)
7,906
(177,262)
CAPEX
(29,249)
(20,800)
(34,064)
Cash from investing activities
128,349
(285,111)
(21,533)
Cash from financing activities
(75,187)
70,158
128,196
FCF
(290,346)
276,457
(194,746)
Balance
Cash
260,522
448,529
415,909
Long term investments
7,859
12,371
15,002
Excess cash
228,934
429,544
399,492
Stockholders' equity
(2,703,632)
(2,447,800)
(941,001)
Invested Capital
6,534,217
6,259,115
6,000,214
ROIC
ROCE
EV
Common stock shares outstanding
742,649
617,983
481,219
Price
1.80
7.78%
1.67
-62.81%
4.49
-73.07%
Market cap
1,336,769
29.53%
1,032,031
-52.24%
2,160,674
-51.91%
EV
1,521,490
1,185,872
2,414,162
EBITDA
98,907
45,491
41,230
EV/EBITDA
15.38
26.07
58.55
Interest
49,264
13,587
39,680
Interest/NOPBT